Use of direct-probe mass spectrometry as a toxicology confirmation method for demoxepam in urine following high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 683, Issue 2, 1996, Pages 199-208

  Essien, Herbert ^a   Lai, S Jason ^a   Binder, Steven R ^a   King, David L ^a  

^a BIO RAD LABORATORIES   (United States)

Author keywords

Demoxepam

Indexed keywords

CHLORDIAZEPOXIDE; DEMOXEPAM; DRUG METABOLITE; NORCHLORDIAZEPOXIDE; NORDAZEPAM;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STABILITY; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TECHNIQUE;

EID: 0030606826     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(96)00119-3     Document Type: Article

References (25)

1. [1] B.A. Koechlin and L. D'Arconte, Anal. Biochem., 5 (1963) 195.
2. [2] M.A. Schwartz, E. Postma and Z. Guat, J. Pharm. Sci., 60 (1971) 1500.
3. [3] D.J. Greenblat, R.I. Shader, S.M. MacLeod and E.M. Sellers, Clin. Pharmacokin., 3 (1978) 381.
4. [4] B.J. Gudzimnowicz, H.F. Martin and J.L. Driscoll, J. Gas Chromatogr., 2 (1964) 265.
5. [5] D.A. Ganes, K.W. Hindmarsh and K.K. Midha, Xenobiotica, 16 (1986) 781.
6. [6] C. Linberg and C. Bogentoft, Acta Pharm. Suec., 12 (1975) 507.
7. [7] A.B. Foster, L.J. Griggs, M. Jarman, J.M.S. van Maanen and H.R. Schulten, Biochem. Pharmacol., 29 (1980) 1977.
8. [8] W. Sadee and E. van der Kleijn, J. Pharm. Sci., 60 (1971) 135.
9. [9] J.R. Joyce, T.S. Bal, R.E. Ardrey, H.M. Stevens and A.C. Moffat, Biomed. J. Mass Spectrom., 11 (1984) 284.
10. [10] Martindale The Extra Pharmacopoeia (edited by J.E. Reynolds) The Pharmaceutical Press, London, 30th ed., p. 607, 1993.
11. [11] M.A. Peat, B.S. Finkle and M.E. Deyman, J. Pharm, Sci., 68 (1979) 1467.
12. [12] T.J. Good and J.S. Andrews, J. Chromatogr. Sci., 19 (1981) 562.
13. [13] U.A.Th. Brinkman, P.L.M. Welling, G. De Vries, A.H.M.T. Scholten and R.W. Frei, J. Chromatogr., 217 (1981) 463.
14. [14] T.B. Vree, A.M. Barrs, Y.A. Hekster and E. Van Der Kleijn, J. Chromatogr., 224 (1981) 519.
15. [15] S.R. Binder, A.K. Adams, M. Regalia, H. Essien and R. Rosenblum, J. Chromatogr., 550 (1991) 449.
16. [16] A.K. Adams, H. Essien and S.R. Binder, Ann. Biol. Clin., 49 (1991) 291.
17. [17] S.R. Binder, D.L. King, S. Dalvie and D. Fretthold, Proc. Am. Acad. Forensic Sci., 1 (1995) 207.
18. [18] I.S. Lurie, D.A. Cooper and R.F.X. Klein, J. Chromatogr., 598 (1992) 59.
19. [19] K. Sato, C.M. Moore, K. Kobayashi, Y. Mizuno and Y. Katsumata, Jpn. J. Forensic Toxicol., 10 (1992) 23.
20. [20] W.R. Anderson, Jr., W. Frick, G.D. Daves, Jr., D.R. Barofsky, I. Yamaguchi, D. Chang, K. Folkers and S. Resell, Biochem. Biophys. Res. Commun., 78 (1977) 372.
21. [21] W.R. Anderson, Jr., W. Frick and G.D. Daves, Jr., J. Am. Chem., 100 (1974) 1974.
22. [22] G.D. Daves, Jr., Acc. Chem. Res., 12 (1979) 359.
23. [23] R.J. Cotter, Anal. Chem., 52 (1980) 1589.
24. [24] J.L. Valentine, R. Middletone and C. Sparks, in preparation.
25. [25] R.C. Baslt and R.H. Cravey, Disposition of Toxic Drugs and Chemicals in Man, Chemical Toxicology Institute, Foster City, CA, 4th ed., 1995, p. 139.